Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$301,212
+$71,326 QoQ
Shares Held
1,197
+13.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3,625
of 4,153 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Penserra Capital Management LLC holds $2,738,678 across 11 Drug Manufacturers - General names. ABBV ranks #3 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
833 | $999,123 | |
| 2 | NVO |
Novo Nordisk A S
|
8,881 | $425,755 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
1,197 | $301,212 | |
| 4 | PFE |
Pfizer Inc
|
9,522 | $229,288 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,760 | $226,160 | |
| 6 | AMGN |
Amgen Inc
|
597 | $216,185 | |
| 7 | AZN |
Astrazeneca PLC
|
1,049 | $198,911 | |
| 8 | JNJ |
Johnson & Johnson
|
336 | $85,333 |
All Filings in ABBV
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $301,212 | 1,197 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $229,886 | 1,057 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $165,654 | 725 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $178,517 | 771 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $160,375 | 864 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $30,170 | 144 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $820,973 | 4,620 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $28,437 | 144 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $24,698 | 144 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $26,222 | 144 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,265,949 | 8,169 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,566,321 | 10,508 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,638,990 | 12,165 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $136,420 | 856 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $4,034,431 | 24,964 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $232,720 | 1,734 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $44,110 | 288 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $504,485 | 3,112 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $725,743 | 5,360 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $42,499 | 394 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $38,297 | 340 | Shares | Defined | 2021-08-12 | |
| 2020-06-30 | $332,830 | 3,390 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||